T1	Treatment 0 14	18F-FDG PET/CT
T2	Treatment 51 108	neoadjuvant lapatinib, trastuzumab, and their combination
T3	Treatment 300 351	Neo-ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab
T4	Treatment 540 598	neoadjuvant lapatinib, trastuzumab, and their combination.
T5	Treatment 604 621	anti-HER2 therapy
T6	Treatment 698 709	paclitaxel.
T7	Treatment 745 764	anti-HER2 therapies
T8	Treatment 900 916	(18)F-FDG PET/CT
T9	Treatment 950 970	anti-HER2 treatment.
T10	Treatment 2255 2311	neoadjuvant trastuzumab, lapatinib, or their combination
T11	Treatment 2328 2341	chemotherapy.
